Insulin lantus vs glargine?

Short answer: Lantus is a brand name for insulin glargine. So, in a basic sense, Lantus and glargine refer to the same medication. There are other glargine products too, including biosimilars and a more concentrated version.

Key points to know:
- Active ingredient: Insulin glargine (basal insulin).
- Brand vs generic: Lantus is the brand name (glargine U-100). Glargine is the generic name.
- Other glargine products:
- Basaglar: a biosimilar to Lantus (glargine U-100).
- Semglee: another glargine U-100 biosimilar.
- Toujeo: a more concentrated form of glargine (glargine U-300), which is longer-acting and has a different dosing/coming-on profile.
- Concentrations:
- Lantus/Basaglar/Semglee: 100 units/mL (U-100).
- Toujeo: 300 units/mL (U-300) – more concentrated and may act a bit differently in practice.
- Dosing and switching:
- For most switches between Lantus and Basaglar/Semglee (U-100 products), doses are typically 1:1, but you should verify with your clinician.
- If switching to Toujeo (U-300), you usually start at about 80% of your previous daily glargine dose and adjust based on blood glucose monitoring.
- It’s important to monitor fasting glucose after any switch and follow your clinician’s instructions.
- Practical differences:
- Injection device: different pens/vials; some people notice small changes in how long the effect lasts.
- Cost and insurance coverage can differ between brands and biosimilars.
- Injection technique is the same (subcutaneous), but you must not mix glargine with other insulins in the same syringe.

Bottom line: Lantus is glargine U-100; glargine is the generic name. There are related products with different concentrations and brand/biosimilar names. If you’re considering switching between these products, talk with your healthcare provider about the right dose and a plan for monitoring your blood glucose. If you want, tell me what specific products you’re comparing (e.g., Lantus vs Basaglar vs Toujeo), and I can summarize the differences for you.